MSB 2.10% $1.17 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-263

  1. 225 Posts.
    lightbulb Created with Sketch. 69
    why would they have reason to think this? as i said before, these treatments are revolutionary and meso is without doubt the frontrunner in the race to commercialization. the treatment either works or it doesnt and it wouldnt be reducing mortality by 60% if it didnt
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.